Secondary analysis of the RESILIENT thrombectomy trial in anterior circulation large-vessel stroke: thrombectomy benefit was restricted to patients under 70 with low small vessel disease burden (OR 4.16); CT small vessel disease mediated the age-outcome association.
Secondary analysis
do Vale Martins-Filho et al. Brain Frailty Rather than Age Alone Mediates the Lack of Benefit for Endovascular Thrombectomy in the Elderly Population of the RESILIENT Trial